Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

laboratoires smb s.a. - fenofibrate, pravastatin - dyslipidémia - Činidlá modifikujúce lipidy - liek pravafenix je indikovaný na liečbu vysoko-ischemická--choroby srdca (ichs)-riziko u dospelých pacientov so zmiešanou dyslipidémiou charakterizovaný vysokou triglyceridov a nízke hladiny hdl-cholesterol (c), ktorých hladiny ldl c sú primerane kontrolované počas na liečba liekom pravastatín v dávke 40 mg v monoterapii.

Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

proveca pharma limited - glycopyrronium bromid - sialorrhea - liečivá na funkčné gastrointestinálne poruchy - symptomatická liečba závažnej sialorrhoe (chronické ochorenie srdca) u detí a dospievajúcich vo veku 3 rokov a starších s chronickými neurologickými poruchami.

Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

meda ab - zaleplon - poruchy spánku a poruchy obsluhy - psycholeptika - sonata je indikovaná na liečbu pacientov s nespavosťou, ktorí majú problémy so zaspávaním. to je indikovaná len vtedy, keď porucha je ťažkou, zakázanie alebo podrobenie jednotlivých mimoriadnej tiesne.

Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

meda ab - zaleplon - poruchy spánku a poruchy obsluhy - psycholeptika - zerene je indikovaný na liečbu pacientov s nespavosťou, ktorí majú ťažkosti so zaspávaním. to je indikovaná len vtedy, keď porucha je ťažkou, zakázanie alebo podrobenie jednotlivých mimoriadnej tiesne.

Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

merck europe b.v. - avelumab - neuroendokrinné nádory - iné antineoplastické činidlá, monoklonálne protilátky, - bavencio je označené ako monotherapy na liečbu dospelých pacientov s metastatickým merkelová bunky karcinómu (mkc). bavencio v kombinácii s axitinib je uvedené, za prvé-line liečbu dospelých pacientov s pokročilým karcinómom obličiek (rcc). bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.

Liên Minh Châu Âu - Tiếng Slovak - EMA (European Medicines Agency)

roche registration gmbh - atezolizumab - carcinoma, transitional cell; carcinoma, non-small-cell lung; urologic neoplasms; breast neoplasms; small cell lung carcinoma - antineoplastické činidlá - urothelial carcinomatecentriq as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc):- after prior platinum containing chemotherapy, or - who are considered cisplatin ineligible, and whose tumours have a pd-l1 expression ≥ 5% (see section 5. non-small cell lung cancer tecentriq, in combination with bevacizumab, paclitaxel and carboplatin, is indicated for the first-line treatment of adult patients with metastatic non-squamous non small cell lung cancer (nsclc). in patients with egfr mutant or alk-positive nsclc, tecentriq, in combination with bevacizumab, paclitaxel and carboplatin, is indicated only after failure of appropriate targeted therapies (see section 5. tecentriq, in combination with nab paclitaxel and carboplatin, is indicated for the first line treatment of adult patients with metastatic non-squamous nsclc who do not have egfr mutant or alk positive nsclc (see section 5. tecentriq as monotherapy is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumours have a pd-l1 expression ≥ 50% tumour cells (tc) or ≥ 10% tumour-infiltrating immune cells (ic) and who do not have egfr mutant or alk-positive nsclc (see section 5. tecentriq ako monotherapy je indikovaný na liečbu dospelých pacientov s lokálne pokročilým alebo metastatickým nsclc po predchádzajúcej chemoterapie. patients with egfr mutant or alk positive nsclc should also have received targeted therapies before receiving tecentriq (see section 5. small cell lung cancertecentriq, in combination with carboplatin and etoposide, is indicated for the first-line treatment of adult patients with extensive-stage small cell lung cancer (es-sclc) (see section 5. hepatocellular carcinomatecentriq, in combination with bevacizumab, is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (hcc) who have not received prior systemic therapy (see section 5. urothelial carcinomatecentriq as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc):- after prior platinum containing chemotherapy, or- who are considered cisplatin ineligible, and whose tumours have a pd-l1 expression ≥ 5% (see section 5. non-small cell lung cancertecentriq as monotherapy is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (nsclc) whose tumours have a pd-l1 expression ≥ 50% tumour cells (tc) or ≥ 10% tumour-infiltrating immune cells (ic) and who do not have egfr mutant or alk-positive nsclc (see section 5. tecentriq ako monotherapy je indikovaný na liečbu dospelých pacientov s lokálne pokročilým alebo metastatickým nsclc po predchádzajúcej chemoterapie. patients with egfr mutant or alk positive nsclc should also have received targeted therapies before receiving tecentriq (see section 5. triple-negative breast cancertecentriq in combination with nab-paclitaxel is indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (tnbc) whose tumours have pd-l1 expression ≥ 1% and who have not received prior chemotherapy for metastatic disease.

Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - pefloxacín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - pefloxacín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - medazepam - 70 - anxiolytica

Slovakia - Tiếng Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - diazepam - 70 - anxiolytica